Device manufacturer, as written on reports
Biosense Webster Irwindale: medical device reports filed with FDA
1,956 reports name it as the manufacturer of the device involved, 2007–2017.
- 1,956
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 19.7%
- classified as malfunction
- 62.3% across all reports
- 7.2%
- classified as death, as reported
- 0.9% across all reports
1,956 medical device reports received by FDA give Biosense Webster Irwindale as the manufacturer of the device involved, 0% of the MAUDE database, from October 2007 to September 2017. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (73.1%), malfunction (19.7%) and death (7.2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| NaviStar ThermoCool | Catheter, percutaneous, cardiac ablation, for treatment of atrial flutter | 462 | 20 | 7% |
| Thermocool Sf Nav Bi-Directional Catheter | Cardiac ablation percutaneous catheter | 193 | 0 | 6.3% |
| Thermocool Smarttouch Bi-Directional Navigation Catheter | Cardiac ablation percutaneous catheter | 87 | 0 | 5% |
| Ez Steer Thermocool Nav Bi-Directional Catheter | Catheter, percutaneous, cardiac ablation, for treatment of atrial flutter | 79 | 0 | 6.3% |
| Navistar Electrophysiology Catheter | Catheter, electrode recording, or probe, electrode recording | 67 | 0 | 6% |
| Preface Guiding Sheath With Multipurpose Curve | Introducer, catheter | 44 | 0 | 0.4% |
| Navi-Star Thermo-Cool Electrophysiology Catheter | Catheter, percutaneous, cardiac ablation, for treatment of atrial flutter | 40 | 2 | 1.9% |
| Navistar Rmt Thermocool Electrophysiology Catheter | Catheter, percutaneous, cardiac ablation, for treatment of atrial flutter | 39 | 0 | 7.1% |
| Lasso 2515 Nav Variable Catheter | Catheter, electrode recording, or probe, electrode recording | 38 | 0 | 0.5% |
| Thermocool Smarttouch Uni-Directional Navigation Catheter | Cardiac ablation percutaneous catheter | 36 | 0 | 4.1% |
| Thermocool Sf Nav Uni-Directional Catheter | Cardiac ablation percutaneous catheter | 35 | 0 | 4.1% |
| Thermocool Smarttouch Sf Bi-Directional Nav Catheter | Cardiac ablation percutaneous catheter | 24 | 0 | 3.4% |
| Ez Steer Nav Bi-Directional Electrophysiology Catheter | Cardiac ablation percutaneous catheter | 18 | 1 | 3.8% |
| Decanav Electrophysiology Catheter | Catheter, electrode recording, or probe, electrode recording | 2 | 4 | 3.3% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LPB | Cardiac ablation percutaneous catheter | 897 | 45.9% |
| OAD | Catheter, percutaneous, cardiac ablation, for treatment of atrial flutter | 502 | 25.7% |
| DRF | Catheter, electrode recording, or probe, electrode recording | 385 | 19.7% |
| DYB | Introducer, catheter | 56 | 2.9% |
| OBJ | Catheter, ultrasound, intravascular | 48 | 2.5% |
| DQK | Computer, diagnostic, programmable | 36 | 1.8% |
| MTD | Catheter, intracardiac mapping, high-density array | 22 | 1.1% |
| GEI | Electrosurgical, cutting & coagulation & accessories | 4 | 0.2% |
| NLH | Catheter, recording, electrode, reprocessed | 2 | 0.1% |
| DYG | Catheter, flow directed | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Biosense Webster Irwindale reports
How many FDA device reports name Biosense Webster Irwindale as manufacturer?
1,956 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
NaviStar ThermoCool (462), Thermocool Sf Nav Bi-Directional Catheter (193), Thermocool Smarttouch Bi-Directional Navigation Catheter (87), Ez Steer Thermocool Nav Bi-Directional Catheter (79) and Navistar Electrophysiology Catheter (67).
Which device types does it report on?
cardiac ablation percutaneous catheter (45.9%), catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (25.7%), catheter, electrode recording, or probe, electrode recording (19.7%) and introducer, catheter (2.9%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.